OptiBiotix Health Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-1.81	-2.04	2.59	6.26	5.8	Upgrade
Depreciation & Amortization	0.21	0.21	0.22	0.29	0.25	Upgrade
Asset Writedown & Restructuring Costs	0	0	-	-	-	Upgrade
Stock-Based Compensation	0.05	0.01	0.01	0.06	0.13	Upgrade
Other Operating Activities	-0.4	0.34	-4.95	-7.43	-6.9	Upgrade
Change in Accounts Receivable	0.03	0.06	1.12	-0.91	-0.04	Upgrade
Change in Inventory	-0.04	-0.01	-0.08	0.08	-0.12	Upgrade
Change in Accounts Payable	0.18	-0.1	-0.02	0.08	-0.04	Upgrade
Operating Cash Flow	-1.77	-1.53	-1.11	-1.57	-0.93	Upgrade
Divestitures	-	-	-0.19	-	-	Upgrade
Sale (Purchase) of Intangibles	-	-	-0.17	-0.19	-0.35	Upgrade
Investment in Securities	0.59	1.11	0.03	2.9	-	Upgrade
Investing Cash Flow	0.59	1.11	-0.33	2.71	-0.35	Upgrade
Issuance of Common Stock	1.29	-	0.49	-	1	Upgrade
Other Financing Activities	-	-	-	-	0.69	Upgrade
Financing Cash Flow	1.29	-	0.49	-	1.69	Upgrade
Net Cash Flow	0.1	-0.42	-0.96	1.14	0.41	Upgrade
Free Cash Flow	-1.77	-1.53	-1.11	-1.57	-0.93	Upgrade
Free Cash Flow Margin	-203.22%	-237.11%	-242.67%	-70.72%	-60.92%	Upgrade
Free Cash Flow Per Share	-0.02	-0.02	-0.01	-0.02	-0.01	Upgrade
Cash Income Tax Paid	-0.06	-	-0.12	-0.19	-	Upgrade
Levered Free Cash Flow	-0.91	-0.89	-0.77	-1.35	-1.02	Upgrade
Unlevered Free Cash Flow	-0.91	-0.89	-0.77	-1.32	-0.99	Upgrade
Change in Net Working Capital	-0.25	0.04	-0.72	0.62	0.32	Upgrade

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.